Skip to content

Baseline HPV16 status and genotype multiplicity independently predict subsequent high-grade cervical lesions in HR-HPV-positive women referred for colposcopy with negative or low-grade cytology: A prospective cohort study.

Oct 2026 · Gynecologic Oncology · Vol 215, pp. 25-31 · 0 citations · 24 references
Medicine

TL;DR

Baseline HPV16 positivity and genotype multiplicity are independent, additive risk factors for HSIL+, with HPV16 plus other HR types marking the highest-risk subgroup, with HPV16 plus other HR types marking the highest-risk subgroup.

Abstract

Objective

To evaluate the prospective risk of high-grade squamous intraepithelial lesion or worse (HSIL+) in high-risk HPV (HR-HPV)positive women, assessing the independent and interactive effects of baseline HPV16-status, genotype multiplicity, and follow-up HPV persistence.

Methods

A prospective cohort of 2562 HR-HPV-positive women referred for colposcopy were categorized into four groups: single non-HPV16, single HPV16, HPV16 plus other HR types, or multiple non-HPV16. HSIL+ risk was analysed using Cox-proportional-hazards-regression, restricted mean survival time (RMST) at 36months, and Fine-Gray competing-risk models. Multivariable logistic regression evaluated concurrent HSIL+ risk associated with follow-up HPV persistence.

Results

Overall, 691 women (27.0%) developed HSIL+. Infection with HPV16 plus other HR types carried the highest risk (adjusted hazard ratio [aHR]2.10, 95%CI: 1.69-2.62) and shorter median HSIL+-free survival than single non-HPV16 infection (24 vs. 54months), corresponding to 5.1 fewer HSIL+-free-months at 36months (p<0.001). Baseline HPV16 positivity and genotype multiplicity exerted independent, additive effects without multiplicative interaction (adjusted p=0.600). Incorporating multiplicity improved model discrimination beyond entry cytology and HPV16 status (concordance index 0.612 vs. 0.587, p<0.001). Results remained robust in competing-risk analyses (subdistribution HR2.03, 95%CI: 1.64-2.52) and after excluding early-treated women (aHR2.00, 95%CI: 1.52-2.62). Follow-up viral persistence strongly correlated with concurrent HSIL+ (aHR5.71-8.59, p<0.001), reflecting a cross-sectional risk correlation complementary to baseline prognostication.

Conclusions

Baseline HPV16 positivity and genotype multiplicity are independent, additive risk factors for HSIL+, with HPV16 plus other HR types marking the highest-risk subgroup. Genotype multiplicity provides distinct clinical predictive value alongside HPV16 status, while follow-up HPV persistence offers complementary, non-redundant information for concurrent risk evaluation in risk-based management strategies.

View source

Similar papers

Open access Sep 2026

Risk factors for HR-HPV persistence and residual or recurrent high-grade squamous intraepithelial neoplasia after LEEP

Background To investigate factors associated with persistent high-risk human papillomavirus (HR-HPV) infection and residual or recurrent disease in patients with high-grade squamous intraepithelial lesions (HSIL) following loop electrosurgical excision procedure (LEEP). Methods A total of 903 patients with pathological...

Li-Ya Wang, Yi-Ran Zhang, Yi Chen et al. · 0 citations
Open access Oct 2026

Risk factors for persistent high-risk HPV infection and recurrence burden of vaginal infections in women with cervical low-grade squamous intraepithelial lesions: a retrospective cohort study

Background Persistent high-risk human papillomavirus (HR-HPV) infection drives cervical carcinogenesis, yet factors determining persistence in women with low-grade squamous intraepithelial lesions (LSIL) remain incompletely characterized. The longitudinal recurrence burden of vaginal infections including aerobic vagini...

Ru Bai, Zi-Shan Tang, Cun-Wei Ji et al. · 0 citations
Open access Oct 2026

Cytology, High-Risk HPV Genotyping, and Histology in Cervical Pathology: A Retrospective Cohort Study

Background/Objectives: Cervical cancer prevention relies on cytology, high-risk human papillomavirus (HR-HPV) testing, and histological confirmation, but these modalities may disagree. We quantified test concordance and determinants of CIN2+ in a specialized gynecologic referral cohort with very low HPV vaccination cov...

Maria-Daniela Vasieș Mazilu, E. Rusu, Jasmina Chiriac et al. · 0 citations
Open access Oct 2026

Shifting High-Risk HPV Genotype Patterns in Histologically Confirmed Cervical HSIL: Temporal Changes and Differential Distribution in Invasive Squamous Cell Carcinoma

High-risk human papillomavirus (HR-HPV) genotypes differ in their oncogenic potential and contribution to cervical precancer and invasive cancer. We investigated temporal changes in HR-HPV genotype patterns in histologically confirmed cervical high-grade squamous intraepithelial lesions (HSIL) and differences between 2...

Cristina Díaz del Arco, Mar Ramírez Mena, Silvia Rojas Calles et al. · 0 citations
Review Open access Sep 2026

HPV-Associated Oropharyngeal Squamous Cell Carcinoma and Persistent Oral High-Risk HPV Detection: A Narrative Review of Longitudinal Assessment, Diagnostic Evaluation, and Surveillance

Currently, no validated population-based screening strategy uses persistent oral high-risk human papillomavirus (HPV) detection to identify individuals at clinically meaningful risk of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC). This narrative review evaluates sampling strategies, virologic assays, li...

A. Promsong, W. Nittayananta · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.